Overview
Lingyu Li practices in Beijing, China. Li is rated as a Distinguished expert by MediFind in the treatment of Leukoplakia. Their top areas of expertise are Leukoplakia, Tongue Cancer, Oral Squamous Cell Carcinoma, and Autosomal Dominant Polycystic Kidney Disease.
Their clinical research consists of co-authoring 25 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 9 articles in the study of Leukoplakia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- LeukoplakiaLi isDistinguished. Learn about Leukoplakia.
- Experienced
- Autosomal Dominant Polycystic Kidney Disease
- BronchiectasisLi isExperienced. Learn about Bronchiectasis.
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Oral Squamous Cell Carcinoma
- Polycystic Kidney Disease
- Tongue CancerLi isExperienced. Learn about Tongue Cancer.